Method and device for acquiring exhaled ammonia gas variable quantity for auxiliary diagnosis of helicobacter pylori infection

By increasing the pH value in the stomach with urea and alkaline reagents and using an ammonia sensor to detect Helicobacter pylori infection, the problem of high cost, complex equipment, and difficult detection in existing technologies has been solved, achieving highly sensitive diagnosis of Helicobacter pylori.

CN121164616APending Publication Date: 2025-12-19HEFEI JIUYAN MEDICINE TECH DEV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202511363072.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-09-23
Publication Date
2025-12-19

AI Technical Summary

Technical Problem

Existing isotope-labeled CO2 urea breath tests are costly, the equipment is complex and difficult to miniaturize, and ammonia is difficult to volatilize into exhaled air in the acidic environment of the stomach, making it difficult to detect Helicobacter pylori.

Method used

By administering urea and alkaline reagents to subjects, the pH value in the stomach is increased, inhibiting the reaction between ammonia and gastric acid. An ammonia sensor is used to detect the concentration change ΔC before and after medication, and diagnosis is made in combination with age-adaptive thresholds.

Benefits of technology

It significantly increased the proportion of ammonia entering exhaled air, enhanced the detection signal of Helicobacter pylori infection, and achieved a diagnosis with high sensitivity and high specificity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN121164616A_ABST
    Figure CN121164616A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of helicobacter pylori detection, and discloses a method for acquiring exhaled ammonia gas variation, which comprises the following steps: S1, acquiring exhaled gas before a subject takes a urea reagent at a first time point, and measuring to obtain a basic concentration value C0 of endogenous ammonia gas; s2, enabling the subject to take a reagent containing urea and an alkaline substance; s3, obtaining expired gas after the subject takes the reagent, and measuring to obtain the concentration value C1 of the ammonia gas. According to the invention, a subject takes the reagent containing urea and alkaline substances, so that the pH value in the stomach is remarkably increased, and ammonia gas is inhibited from reacting with gastric acid to generate ammonium ions, thereby increasing the proportion of ammonia gas generated by decomposing urea by helicobacter pylori urease into exhaled gas and enhancing a detection signal. By comparing the variable quantity of ammonia gas concentration in expired gas before and after medicine taking and combining with a preset age adaptability threshold value, high-sensitivity and high-specificity judgment on helicobacter pylori infection is realized.
Need to check novelty before this filing date? Find Prior Art

Description

TECHNICAL FIELD

[0001] The present application relates to the technical field of Helicobacter pylori detection, and particularly relates to a method and device for obtaining breath ammonia gas change amount for assisting in diagnosing Helicobacter pylori infection. BACKGROUND

[0002] Helicobacter pylori is the main pathogenic factor of chronic gastritis, peptic ulcer and gastric cancer. The current "gold standard" for clinically diagnosing Hp infection is urea breath test (UBT), the principle of which is that after patients take isotope (such as 13 C or 14 C) labeled urea, if there is Hp in the stomach, the urease produced by the Hp will decompose the urea into carbon dioxide (CO2) and ammonia gas (NH3), and the infection or non-infection is determined by detecting the abundance change of isotope-labeled CO2 in exhaled air. However, the existing isotope-labeled CO2 urea breath test has the following limitations:

[0003] High cost: expensive isotope-labeled urea needs to be used, and precise equipment such as mass spectrometer or infrared spectrometer is needed for detection, resulting in high cost of single detection.

[0004] Radiation concerns: 14 C has weak radioactivity, although it is within the safety range, but it may still cause concerns of some patients (such as pregnant women and children).

[0005] Complex equipment: the detection equipment is not easy to miniaturize, and it is difficult to popularize in primary medical institutions or families.

[0006] Although urea decomposition necessarily produces ammonia gas, ammonia gas is an alkaline gas, and its pKa is about 9.25. This means that in a low pH environment (such as gastric acid, pH 1.5-3.5), ammonia gas will immediately react with hydrochloric acid (HCl) to generate ammonium ion (NH4 + ), which is water-soluble and difficult to volatilize into the gas phase. Reaction formula: NH3+HCl→NH4Cl. Therefore, under the standard gastric acid environment, most of the ammonia gas produced by urea decomposition is neutralized, and only a small amount can enter the exhaled air.

[0007] And ammonia gas is easily soluble in water, the background concentration in the body fluctuates greatly, and it is difficult to distinguish from endogenous ammonia. For a long time, the industry has generally believed that it is not suitable to be used as a diagnostic marker of Hp. The present application aims to overcome these technical biases and provide a completely new solution based on ammonia gas detection. SUMMARY

[0008] To solve the technical problems proposed in the background art, the present application provides a method and device for obtaining breath ammonia gas change amount for assisting in diagnosing Helicobacter pylori infection.

[0009] This invention is achieved using the following technical solution: a method for obtaining changes in exhaled ammonia levels to aid in the diagnosis of Helicobacter pylori infection, comprising the following steps:

[0010] S1. Obtain the subject's exhaled breath before taking the urea reagent at the first time point and measure the baseline concentration value C0 of endogenous ammonia.

[0011] S2. The subject is given a reagent containing urea and an alkaline substance;

[0012] S3. Obtain the exhaled breath of the subject after taking the reagent, and measure the concentration value of ammonia C1;

[0013] S4. Calculate the change ΔC between the concentration value C1 and the baseline concentration value C0;

[0014] S5. Output the change ΔC; when ΔC is greater than the threshold, output a first signal; when ΔC is less than or equal to the threshold, output a second signal.

[0015] Preferably, if the baseline ammonia concentration C0 > 500 ppb is obtained at the first time point, then the exhaled breath of the subject before taking the urea reagent is obtained again after an interval Δt to obtain C0. 0i Until C 0i <500 ppb, Δt is 5 min, at this time the baseline concentration value C0' = (C0 + C 01 +……+C 0i ) / i, where i is a natural number.

[0016] Preferably, the alkaline substance is sodium bicarbonate, calcium carbonate, or magnesium hydroxide.

[0017] Preferably, the step of obtaining the exhaled breath of the subject after taking the reagent and measuring the ammonia concentration value C1 specifically includes:

[0018] Exhaled breath samples were collected at multiple predetermined time points after the reagent was administered.

[0019] The ammonia concentration in exhaled breath samples collected at each time point is recorded in real time to form a curve showing the change in concentration over time.

[0020] The peak concentration is automatically identified from the concentration-time curve;

[0021] The peak concentration is taken as the concentration value C1.

[0022] Preferably, the plurality of predetermined time points include the 5th minute, 10th minute, 15th minute and 20th minute after medication, and the duration of collecting exhaled breath samples at each predetermined time point is 3 seconds.

[0023] Preferably, the step of obtaining the exhaled breath of the subject after taking the reagent and measuring the ammonia concentration value C1 includes:

[0024] Exhaled breath was collected at multiple time points, and a series of ammonia concentration values ​​were obtained.

[0025] If the concentration value measured at a certain time point fluctuates more than a preset ratio compared with the concentration value measured at the previous time point, the concentration value will be marked as suspicious data, and a supplementary measurement will be triggered after a preset delay time.

[0026] The concentration value C is obtained by taking the maximum value of the effective concentration values ​​obtained from n consecutive collections. 1;

[0027] Preferably, the preset ratio is 30%, n=3, and the preset delay time is 3 minutes.

[0028] Preferably, the step of outputting the first signal or the second signal specifically includes:

[0029] Obtain the age information of the subject; based on the age information, select a corresponding positive judgment threshold from multiple preset thresholds;

[0030] The change ΔC is compared with the selected positive judgment threshold;

[0031] When ΔC is greater than the threshold, the first signal is output;

[0032] When ΔC is less than or equal to the threshold, a second signal is output.

[0033] Preferably, the plurality of preset thresholds include: a first threshold applicable to adults, a second threshold applicable to children, and a third threshold applicable to the elderly, wherein the second threshold < the first threshold < the third threshold.

[0034] This invention also proposes a device for obtaining changes in exhaled ammonia levels to aid in the diagnosis of Helicobacter pylori infection, which is used to implement the above-mentioned method, comprising:

[0035] The airway system is used to collect and deliver the subject's exhaled air;

[0036] A sensing system, connected to the gas path system, is used to detect the ammonia concentration in the exhaled air;

[0037] The control and data processing system, electrically connected to the pneumatic system and the sensing system, is configured as follows:

[0038] The gas path system is controlled to acquire the subject's exhaled breath before taking the urea reagent at a first time point, and to receive the baseline concentration value C0 of endogenous ammonia measured by the sensing system.

[0039] The gas path system is controlled to acquire the exhaled breath of the subject after ingesting a reagent containing urea and an alkaline substance, and to receive the ammonia concentration value C1 measured by the sensing system.

[0040] Calculate the change ΔC between the concentration value C1 and the baseline concentration value C0;

[0041] The change ΔC is output; when ΔC is greater than a preset threshold, a first signal is output; when ΔC is less than or equal to the preset threshold, a second signal is output.

[0042] The gas path system includes: a mouthpiece, a one-way valve, a gas pretreatment unit, and a gas sampling pump. The mouthpiece is used to receive the subject's exhaled air; the one-way valve is connected to the mouthpiece to ensure unidirectional gas flow; the gas pretreatment unit is connected to the one-way valve to remove interfering components from the exhaled air; and the gas sampling pump is used to deliver the gas to the sensing system.

[0043] The gas pretreatment unit includes a drying tube and an impurity adsorption filter; the drying tube is used to remove water vapor from exhaled air; the impurity adsorption filter is used to adsorb volatile organic compound interfering substances in exhaled air.

[0044] The sensing system is an ammonia sensor based on the principles of metal oxide semiconductor, functionalized carbon nanotubes, or laser absorption spectroscopy, with a detection limit at the ppb level.

[0045] The control and data processing system is also configured to: if the initial measured CO > 500 ppb, control the gas path system to collect a baseline exhaled gas sample again after a predetermined time interval, and take the average value of multiple measurements as the final CO.

[0046] The control and data processing system is also configured to: control the gas path system to collect exhaled gas samples at multiple predetermined time points after taking the reagent; record the ammonia concentration value at each time point in real time to form a concentration-time curve; and automatically identify the peak concentration from the curve and use it as C1.

[0047] Compared with the prior art, the beneficial effects of the present invention are as follows:

[0048] The method proposed in this invention significantly increases the gastric pH by having subjects ingest a reagent containing urea and an alkaline substance (such as sodium bicarbonate), inhibiting the reaction of ammonia with gastric acid to produce ammonium ions. This substantially increases the proportion of ammonia produced by the decomposition of urea by Helicobacter pylori urease entering the exhaled air, greatly enhancing the detection signal. By comparing the change in ammonia concentration in exhaled air (ΔC) before and after medication administration, and combining this with a preset age-adaptive threshold, a highly sensitive and specific detection of Helicobacter pylori infection is achieved. Attached Figure Description

[0049] Figure 1 This is a flowchart of the acquisition method proposed in this invention;

[0050] Figure 2 This is a structural block diagram of the acquisition device proposed in this invention;

[0051] Figure 3 This is a graph showing the change in ammonia concentration during the measurement process when Helicobacter pylori is present in the stomach in Example 3 of the present invention.

[0052] Figure 4 This is a graph showing the change in ammonia concentration during the measurement process when Helicobacter pylori is not present in the stomach, as described in Example 3 of the present invention. Detailed Implementation

[0053] The technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative effort are within the scope of protection of the present invention.

[0054] Example 1:

[0055] This embodiment describes a method for obtaining changes in exhaled ammonia levels to aid in the diagnosis of Helicobacter pylori infection, based on sodium bicarbonate.

[0056] Subjects underwent Helicobacter pylori infection screening:

[0057] In a calm state, the subject exhaled continuously into the detection device for 3-5 seconds through the mouthpiece. The device's air pump collected approximately 500 ml of exhaled air, which, after passing through a pretreatment unit (with a built-in dilute sulfuric acid scrubber to remove alkaline interfering substances), was detected by a highly selective metal-oxide-semiconductor (MOS) ammonia sensor. The system recorded and displayed the baseline endogenous ammonia concentration C0 = 98 ppb.

[0058] The subject immediately took one tablet orally, composed of 75 mg of pharmaceutical-grade urea and 500 mg of sodium bicarbonate (baking soda), with 50 ml of warm water. Baking soda rapidly neutralizes gastric acid (HCl), significantly increasing the local pH value in the stomach. The reaction is: NaHCO3 + HCl → NaCl + H2O + CO2. By creating a relatively neutral microenvironment, the ammonia (NH3) produced by the decomposition of urea by Helicobacter pylori urease exists to the maximum extent in molecular form, rather than being rapidly protonated into water-soluble ammonium ions (NH4+). +This greatly facilitates the diffusion and absorption of ammonia through the gastric mucosa into the bloodstream, and ultimately into the exhaled air via gas exchange in the alveoli of the lungs, thus significantly amplifying the detection signal.

[0059] After taking the reagent, the subjects sat quietly and waited. To capture the peak ammonia concentration, the subjects exhaled into the detection device again at 10, 15, and 20 minutes after taking the reagent.

[0060] The device automatically recorded three ammonia concentration measurements: 125 ppb, 415 ppb, and 380 ppb. The data processing system automatically selected the peak concentration C1 = 415 ppb as the target value.

[0061] The system calculated the concentration change ΔC = C1 - C0 = 415 - 98 = 317 ppb. The preset positive threshold for this device is ΔC > 150 ppb. Therefore, the system automatically analyzed and displayed the diagnostic result: "Positive for Helicobacter pylori test." This result was subsequently verified and confirmed to be consistent with the standard ¹³C-urea breath test.

[0062] In this embodiment, the reagent formulation, dosage, and administration method are as shown in the table below, according to different population groups:

[0063] Population type Urea dose Baking soda dose Dosage form Administration Adults (18-60 years) 75 mg 500 mg Tablets / effervescent tablets 50-100 ml of warm water Children (3-17 years) 30-50 mg 200-300 mg Granules Mixed with 5 ml of juice / milk Pregnant women / seniors 60 mg 400 mg Enteric-coated tablets Swallowed whole on an empty stomach (to avoid stomach irritation)

[0064] Furthermore, 0.5% L-arabinose can be added to the reagent (to promote the uniform distribution of urea in the stomach), reducing detection deviations caused by excessively high local drug concentrations. Experimental verification has shown that this can improve ΔC stability by 12%.

[0065] Example 2:

[0066] This embodiment proposes a detection device for implementing the above method, including a gas path system, a sensing system, and a control and data processing system.

[0067] In this scheme, the gas path system is used to collect and deliver the subject's exhaled air; the gas path system includes a mouthpiece, a one-way valve, a gas pretreatment unit, and a gas sampling pump.

[0068] More specifically, the mouthpiece is used to receive the subject's exhaled air and is typically a disposable hygienic accessory; a one-way valve is connected to the mouthpiece to ensure unidirectional gas flow and prevent backflow from contaminating the sensor or gas path; a gas pretreatment unit is connected to the one-way valve to remove interfering components from the exhaled air.

[0069] As an optional embodiment of the present invention, the gas pretreatment unit includes a drying tube, an impurity adsorption filter, and a gas sampling pump. The drying tube is used to remove water vapor from exhaled air, efficiently removing water vapor (saturated moisture) while retaining the target gas ammonia as much as possible. The impurity adsorption filter is used to adsorb volatile organic compound (VOC) interfering substances in exhaled air. It is filled with modified activated carbon or other adsorption materials to selectively adsorb common in vivo VOCs such as ethanol, acetone, and hydrogen sulfide, greatly improving the specificity of subsequent detection. The drying tube has a built-in selective permeation membrane, the impurity adsorption filter is filled with modified activated carbon, and the gas sampling pump is used to deliver the gas to the sensing system. A miniature gas pump is used to precisely control the inhalation flow rate and sampling volume, ensuring consistent measurement conditions for each measurement.

[0070] In this solution, the sensing system is connected to the gas path system and is used to detect the ammonia concentration in the exhaled breath. The sensing system is an ammonia sensor based on the principles of metal oxide semiconductor, functionalized carbon nanotubes, or laser absorption spectroscopy, with a detection limit at the ppb level to meet the detection requirements for low concentrations of ammonia in exhaled breath.

[0071] In this scheme, the control and data processing system, electrically connected to the pneumatic system and the sensing system, is configured as follows:

[0072] The gas path system is controlled to acquire the subject's exhaled breath before taking the urea reagent at a first time point, and to receive the baseline concentration value C0 of endogenous ammonia measured by the sensing system.

[0073] The gas path system is controlled to acquire the exhaled breath of the subject after ingesting a reagent containing urea and an alkaline substance, and to receive the ammonia concentration value C1 measured by the sensing system.

[0074] Calculate the change ΔC between the concentration value C1 and the baseline concentration value C0;

[0075] The change ΔC is output; when ΔC is greater than a preset threshold, a first signal is output; when ΔC is less than or equal to the preset threshold, a second signal is output.

[0076] Furthermore, the control and data processing system also includes a human-machine interface for displaying the change ΔC, the first signal, or the second signal.

[0077] The control and data processing system is also configured to:

[0078] If the initial measured CO > 500 ppb, the airway system is controlled to collect baseline exhaled air samples again after a predetermined interval, and the average value of multiple measurements is taken as the final CO.

[0079] The control and data processing system is also configured to:

[0080] The gas system is controlled to collect exhaled breath samples at multiple predetermined time points after the reagent is taken;

[0081] Real-time recording of ammonia concentration values ​​at various time points to generate a concentration-time curve;

[0082] The peak concentration is automatically identified from the curve and used as C1.

[0083] As an optional embodiment of the present invention, the control and data processing system integrates a data transmission module for uploading the C0, C1, ΔC, detection time, and subject information to an external system.

[0084] The detection device also includes a calibration system, which includes a standard ammonia gas source for periodically and automatically calibrating the sensing system.

[0085] Example 3:

[0086] This embodiment presents a reagent containing urea and an alkaline substance for oral administration to test subjects. The reagent is formulated as a powder. 100 mg of urea and 600 mg of sodium citrate (a mild alkaline buffer) are mixed and packaged in an aluminum foil packet. The subject pours the powder into a cup and dissolves it in 50 ml of warm water. Sodium citrate produces an alkaline effect during metabolism, which can also neutralize stomach acid, raise pH, and enhance ammonia signaling, and its taste is more acceptable to children.

[0087] To demonstrate the effectiveness of this method, we conducted a preliminary control experiment:

[0088] Control group (receiving only 75mg urea): Hp-positive patients (via 13 The average value of the change in exhaled ammonia (ΔC) confirmed by C-UBT was 85±45 ppb, which largely overlapped with the negative patient group, making it difficult to distinguish.

[0089] In the experimental group (administered 75mg urea + 500mg sodium bicarbonate): the mean ΔC value of the same batch of Hp-positive patients jumped to 350±120ppb, while the mean ΔC value of Hp-negative patients remained at a low level of 50±30ppb. The data separation between the two groups was extremely high, *p-value<0.001, demonstrating the significant enhancement effect of alkaline additives on signal intensity and their excellent diagnostic discrimination ability.

[0090] Reference Figure 3 At time T=0min (before medication): the baseline concentration C0 was measured to be 100 ppb.

[0091] After taking the medication: Due to the presence of Helicobacter pylori in the stomach, the urease produced by it rapidly decomposes the ingested urea, generating a large amount of ammonia.

[0092] Peak concentration: Ammonia is absorbed into the blood and exhaled, resulting in a very significant peak concentration (C1≈450ppb) about 10-15 minutes after administration.

[0093] ΔC value: The concentration change ΔC = C1 - C0 = 350 ppb, which is much higher than the preset positive threshold (e.g., 150 ppb), so it is judged as positive.

[0094] Reference Figure 4 At time T=0min (before medication): the baseline concentration C0 (approximately 90 ppb) was measured.

[0095] After taking the medication: Since there is no Helicobacter pylori in the stomach, urea is not broken down, so no additional ammonia is produced.

[0096] Concentration changes: The concentration of ammonia in exhaled breath fluctuates only slightly and randomly around the baseline level (possibly caused by factors such as diet and metabolism), without any obvious peaks.

[0097] ΔC value: The maximum concentration change ΔC << 150 ppb (positive threshold, shown by the red dashed line), therefore it is judged as negative.

[0098] All calculations involved in the embodiments are dimensionless numerical calculations, and the preset parameters and thresholds in the calculations are set by those skilled in the art according to the actual situation.

[0099] The above embodiments can be implemented, in whole or in part, by software, hardware, firmware, or any other combination thereof. When implemented using software, the above embodiments can be implemented, in whole or in part, in the form of a computer program product.

[0100] Those skilled in the art will recognize that the modules and algorithm steps of the various examples described in conjunction with the embodiments disclosed herein can be implemented in electronic hardware, or a combination of computer software and electronic hardware. Whether these functions are implemented in hardware or software depends on the specific application and inventive constraints of the technical solution. Those skilled in the art can use different methods to implement the described functions for each specific application, but such implementation should not be considered beyond the scope of this application.

[0101] In addition, the functional modules in the various embodiments of this application can be integrated into one processing module, or each module can exist physically separately, or two or more modules can be integrated into one module.

[0102] In the several embodiments provided in this application, it should be understood that the disclosed systems, apparatuses, and methods can be implemented in other ways. For example, the apparatus embodiments described above are merely illustrative; for instance, the division of modules is only a logical functional division, and in actual implementation, there may be other division methods. For example, multiple modules or components may be combined or integrated into another system, or some features may be ignored or not executed. Furthermore, the coupling or direct coupling or communication connection shown or discussed may be through some interfaces; the indirect coupling or communication connection between apparatuses or modules may be electrical, mechanical, or other forms.

[0103] The above description is merely a specific embodiment of this application, but the scope of protection of this application is not limited thereto. Any variations or substitutions that can be easily conceived by those skilled in the art within the scope of the technology disclosed in this application should be included within the scope of protection of this application. Therefore, the scope of protection of this application should be determined by the scope of the claims.

[0104] In conclusion, the above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present invention should be included within the protection scope of the present invention.

Claims

1. A method for obtaining changes in exhaled ammonia levels to aid in the diagnosis of Helicobacter pylori infection, characterized in that, Includes the following steps: S1. Obtain the subject's exhaled breath before taking the urea reagent at the first time point and measure the baseline concentration value C0 of endogenous ammonia. S2. The subject is given a reagent containing urea and an alkaline substance; S3. Obtain the exhaled breath of the subject after taking the reagent, and measure the concentration value of ammonia C1; S4. Calculate the change ΔC between the concentration value C1 and the baseline concentration value C0; S5. Output the change ΔC; when ΔC is greater than the threshold, output a first signal; when ΔC is less than or equal to the threshold, output a second signal.

2. The method for obtaining changes in exhaled ammonia levels to aid in the diagnosis of Helicobacter pylori infection according to claim 1, characterized in that, If the baseline ammonia concentration C0 > 500 ppb is obtained at the first time point, then the exhaled breath of the subject before taking the urea reagent is obtained again at an interval Δt to obtain C. 0i Until C 0i <500 ppb, Δt is 5 min, at this time the baseline concentration value C0' = (C0 + C 01 +……+C 0i ) / i, where i is a natural number.

3. The method for obtaining changes in exhaled ammonia levels to aid in the diagnosis of Helicobacter pylori infection according to claim 1, characterized in that, The alkaline substance is sodium bicarbonate, calcium carbonate, or magnesium hydroxide.

4. The method for obtaining changes in exhaled ammonia levels to aid in the diagnosis of Helicobacter pylori infection according to claim 1, characterized in that, The step of obtaining the exhaled breath of the subject after taking the reagent and measuring the ammonia concentration value C1 specifically includes: Exhaled breath samples were collected at multiple predetermined time points after the reagent was administered. The ammonia concentration in exhaled breath samples collected at each time point is recorded in real time to form a curve showing the change in concentration over time. The peak concentration is automatically identified from the concentration-time curve; The peak concentration is taken as the concentration value C1; The multiple predetermined time points include the 5th minute, 10th minute, 15th minute and 20th minute after medication, and the duration of collecting exhaled breath samples at each predetermined time point is 3 seconds.

5. The method for obtaining changes in exhaled ammonia levels to aid in the diagnosis of Helicobacter pylori infection according to claim 1, characterized in that, The step of obtaining the exhaled breath of the subject after taking the reagent and measuring the ammonia concentration value C1 includes: Exhaled breath was collected at multiple time points, and a series of ammonia concentration values ​​were obtained. If the concentration value measured at a certain time point fluctuates more than a preset ratio compared with the concentration value measured at the previous time point, the concentration value will be marked as suspicious data, and a supplementary measurement will be triggered after a preset delay time. The concentration value C1 is obtained by taking the maximum value of the effective concentration values ​​obtained from n consecutive collections.

6. The method for obtaining changes in exhaled ammonia levels to aid in the diagnosis of Helicobacter pylori infection according to claim 1, characterized in that, The preset ratio is 30%, n=3, and the preset delay time is 3 minutes.

7. The method for obtaining changes in exhaled ammonia levels to aid in the diagnosis of Helicobacter pylori infection according to claim 1, characterized in that, The specific steps for outputting the first signal or the second signal are as follows: Obtain the age information of the subject; based on the age information, select a corresponding positive judgment threshold from multiple preset thresholds; The change ΔC is compared with the selected positive judgment threshold; When ΔC is greater than the threshold, the first signal is output; When ΔC is less than or equal to the threshold, a second signal is output.

8. The method for obtaining changes in exhaled ammonia levels to aid in the diagnosis of Helicobacter pylori infection according to claim 7, characterized in that, The plurality of preset thresholds include: a first threshold applicable to adults, a second threshold applicable to children, and a third threshold applicable to the elderly, wherein the second threshold < the first threshold < the third threshold.

9. A device for obtaining changes in exhaled ammonia levels to aid in the diagnosis of Helicobacter pylori infection, used to implement the method as described in any one of claims 1-8, characterized in that, include: The airway system is used to collect and deliver the subject's exhaled air; A sensing system, connected to the gas path system, is used to detect the ammonia concentration in the exhaled air; The control and data processing system, electrically connected to the pneumatic system and the sensing system, is configured as follows: The gas path system is controlled to acquire the subject's exhaled breath before taking the urea reagent at a first time point, and to receive the baseline concentration value C0 of endogenous ammonia measured by the sensing system. The gas path system is controlled to acquire the exhaled breath of the subject after ingesting a reagent containing urea and an alkaline substance, and to receive the ammonia concentration value C1 measured by the sensing system. Calculate the change ΔC between the concentration value C1 and the baseline concentration value C0; Output the change ΔC; when ΔC is greater than a preset threshold, output a first signal; When ΔC is less than or equal to the preset threshold, a second signal is output.

10. A device for obtaining changes in exhaled ammonia levels to aid in the diagnosis of Helicobacter pylori infection, the gas path system comprising: The system includes a mouthpiece, a one-way valve, a gas pretreatment unit, and a gas sampling pump. The mouthpiece is used to receive the subject's exhaled air. The one-way valve, connected to the mouthpiece, ensures unidirectional gas flow. The gas pretreatment unit, connected to the one-way valve, removes interfering components from the exhaled air. The gas sampling pump delivers the gas to the sensing system. The gas pretreatment unit includes a drying tube and an impurity adsorption filter; the drying tube is used to remove water vapor from exhaled air. Impurity adsorption filter cartridge, used to adsorb volatile organic compound interfering substances in exhaled air; The sensing system is an ammonia sensor based on the principles of metal oxide semiconductor, functionalized carbon nanotubes, or laser absorption spectroscopy, with a detection limit at the ppb level. The control and data processing system is also configured to: if the first measured CO > 500 ppb, control the gas path system to collect a baseline exhaled gas sample again after a predetermined time interval, and take the average value of multiple measurements as the final CO. The control and data processing system is also configured to: control the gas path system to collect exhaled gas samples at multiple predetermined time points after taking the reagent; record the ammonia concentration value at each time point in real time to form a concentration-time curve; and automatically identify the peak concentration from the curve and use it as C1.